Genomtec S.A. Elevator Pitch | Revolutionizing Diagnostics with an Innovative Mobile Molecular Platform with CEO  episode artwork

EPISODE · Feb 20, 2022 · 15 MIN

Genomtec S.A. Elevator Pitch | Revolutionizing Diagnostics with an Innovative Mobile Molecular Platform with CEO

from Investor Insights from CEOs & CFOs | seat11a · host seat11a.com

Genomtec S.A. Elevator Pitch: Key Takeaways Genomtec S.A.: Pioneering Advances in Diagnostic Technology Embark on a journey with Genomtec S.A., a trailblazing firm committed to transforming diagnostics with their state-of-the-art mobile molecular platform, Genomtec®ID.   Led by CEO Miron Tokarski, this video presentation unfolds Genomtec’s mission, cutting-edge technology, and forward-looking prospects. Gain an in-depth understanding of the powerhouse team behind this disruptive project, and discover how their Point-Of-Care (POC) analyser makes rapid, accurate clinical molecular analysis feasible beyond conventional lab environments.   Understand the developmental milestones, competitive landscape, and strategic pipeline of the Genomtec®ID system. Learn how this novel system, powered by the company’s patented SNAAT® isothermal and microfluidic technology, delivers ultra-fast results in as little as 15 minutes.   The presentation sheds light on Genomtec’s manufacturing process, their collaboration with global Contract Manufacturing Organizations (CMOs), and their progress in securing market authorisation and product registration for their SARS-CoV-2 EvaGreen® RT-LAMP diagnostic tests.   Join us in this insightful video and explore how Genomtec S.A. is steering the future of diagnostics with innovative solutions and strategic collaborations. CEO Miron Tokarski Guides Through Genomtec’s Mission and TechnologyDeveloping the Genomtec®ID System: Milestones and Strategic ApproachesManufacturing, Collaboration, and Market Authorization StrategiesExploring the Future of Diagnostics with Genomtec S.A. ▶️ Other videos:Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/ Company Presentation: https://seat11a.com/investor-relations-company-presentation/ Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/ Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/ ESG Presentation: https://seat11a.com/investor-relations-esg/ T&C This publication is for informational purposes only and does not constitute investment advice. By using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

Episode metadata supplied by the publisher feed · Published Feb 20, 2022

Embed this episode

Ready to play

Genomtec S.A. Elevator Pitch | Revolutionizing Diagnostics with an Innovative Mobile Molecular Platform with CEO

0:00 15:47

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Investor Insights from CEOs & CFOs | seat11a?

This episode is 15 minutes long.

When was this Investor Insights from CEOs & CFOs | seat11a episode published?

This episode was published on February 20, 2022.

Can I download this Investor Insights from CEOs & CFOs | seat11a episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!